Product NDC: | 50580-728 |
Proprietary Name: | ZYRTEC-D |
Non Proprietary Name: | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
Active Ingredient(s): | 5; 120 mg/1; mg/1 & nbsp; Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50580-728 |
Labeler Name: | McNeil Consumer Healthcare Div McNeil-PPC, Inc |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA021150 |
Marketing Category: | NDA |
Start Marketing Date: | 20080101 |
Package NDC: | 50580-728-12 |
Package Description: | 2 BLISTER PACK in 1 CARTON (50580-728-12) > 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Code | 50580-728-12 |
Proprietary Name | ZYRTEC-D |
Package Description | 2 BLISTER PACK in 1 CARTON (50580-728-12) > 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Product NDC | 50580-728 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080101 |
Marketing Category Name | NDA |
Labeler Name | McNeil Consumer Healthcare Div McNeil-PPC, Inc |
Substance Name | CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 5; 120 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |